Race as a Contributor to Stromal Modulation of Tumor Progression.
Mamatha KakarlaSathyavathi ChallaSivaKanakaSimon W HaywardOmar E FrancoPublished in: Cancers (2021)
Stromal cells play crucial roles in tumor development and are increasingly attractive targets for therapy. There are considerable racial disparities in the incidence and progression of many tumors, reflecting both environmental exposure and genetic differences existing between races. Tumorigenesis and tumor progression are linked to both the propensity to suffer an initiating event and the host response to such an event once it occurs, contributing to incidence and outcomes. In this review, we focused on racial disparities in the tumor microenvironment (TME) of different cancers as potential modulators of growth, metastasis, and response to treatment. Several studies suggest that the TME in AA has a distinct tumor biology and may facilitate both early onset and aggressive tumor growth while inhibiting anti-tumorigenic properties. The TME of AA patients often exhibits an immunosuppressive microenvironment with a substantial enrichment of immune inflammatory pathways and genes. As a result, AA patients can potentially benefit more from treatment strategies that modulate the immune system. Focusing on TME components for diagnostic and therapeutic purposes to address racial disparities is a promising area of investigation. Future basic and clinical research studies on personalized cancer diagnosis and treatment should acknowledge the significance of TME in racial disparities.
Keyphrases
- early onset
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- stem cells
- signaling pathway
- late onset
- african american
- oxidative stress
- risk factors
- small molecule
- gene expression
- adipose tissue
- climate change
- skeletal muscle
- papillary thyroid
- replacement therapy
- current status
- combination therapy
- cell therapy
- glycemic control